Cadila Healthcare is currently trading at Rs. 645.45, up by 15.75 points or 2.50% from its previous closing of Rs. 629.70 on the BSE.
The scrip opened at Rs. 634.95 and has touched a high and low of Rs. 673.70 and Rs. 632.80 respectively. So far 848084 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 673.70 on 12-May-2021 and a 52 week low of Rs. 321.30 on 13-May-2020.
Last one week high and low of the scrip stood at Rs. 673.70 and Rs. 592.95 respectively. The current market cap of the company is Rs. 66661.00 crore.
The promoters holding in the company stood at 74.88%, while Institutions and Non-Institutions held 16.53% and 8.40% respectively.
Cadila Healthcare’s wholly owned material subsidiary -- Zydus Animal Health and Investment (ZAHL) has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (together Definitive Agreements) for disposal of its Animal Healthcare Established Markets Undertaking (having animal healthcare business in India and certain other countries) to Zenex Animal Health India (formerly known as Nutrizvit Animal Health India), by way of a slump sale, without values being assigned to the individual assets and liabilities on debt free and cash free basis, subject to certain closing date adjustments specified in the BTA, with effect from such date, in such manner and on such terms and conditions, as specified in the Definitive Agreements.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1620.50 |
Dr. Reddys Lab | 6171.85 |
Cipla | 1494.65 |
Zydus Lifesciences | 1013.75 |
Lupin | 1617.85 |
View more.. |